Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,226 public trials 1,176 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Recruiting

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

NCT06095583

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Limited-stage Small Cell Lung Cancer (LS-SCLC), +8 more
Locations
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • Xiangya Hospital Central South University Changsha, Hunan, China
  • The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • The First Hospital of China Medical University Shenyang, Liaoning, China
View all 76 locations
View Trial Details
Recruiting

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

NCT07195695

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ClinRé 001-022 (Premier Cancer Care and Infusion Center) Fresno, California, United States
  • OPN Healthcare, Inc. Glendale, California, United States
  • University of California Irvine Irvine, California, United States
  • Sutter Health Roseville, California, United States
View all 199 locations
View Trial Details
Recruiting

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

NCT06712355

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • ACRC Arizona Clinical Research Center Tucson, Arizona, United States
  • Clermont Oncology Center Clermont, Florida, United States
  • Cancer Care Centers of Brevard, Inc Palm Bay, Florida, United States
  • Northside Hospital Atlanta Atlanta, Georgia, United States
View all 221 locations
View Trial Details
Recruiting

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT07680764

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Local Institution - 0170 Athens, Georgia, United States
  • Local Institution - 0034 Lexington, Kentucky, United States
  • Local Institution - 0171 Lexington, Kentucky, United States
  • Local Institution - 0123 Baltimore, Maryland, United States
View all 71 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT06568939

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Ironwood Cancer and Research Center /ID# 276370 Chandler, Arizona, United States
  • University of Arkansas for Medical Sciences /ID# 272923 Little Rock, Arkansas, United States
  • Valkyrie Clinical Trials /ID# 271322 Los Angeles, California, United States
  • Yale New Haven Hospital /ID# 271584 New Haven, Connecticut, United States
View all 80 locations
View Trial Details
Recruiting

A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3

NCT04429087

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Winship Cancer Institute Atlanta, Georgia, United States
  • University of Maryland School of Medicine Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)

NCT07431827

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Instituto Alexander Fleming ( Site 0310) Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
  • Sanatorio Parque ( Site 0311) Rosario, Santa Fe Province, Argentina
  • Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 0306) CABA, Argentina
  • Centro de Educación Médica e Investigaciones clínicas "Dr. Norberto Quirno" (CEMIC) ( Site 0309) CABA, Argentina
View all 72 locations
View Trial Details
Recruiting

An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe

NCT05363319

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Klinikum Klagenfurt Klagenfurt, Carinthia, Austria
  • Salzburger Landeskliniken (SALK) Salzburg, Austria
  • Le Groupe Hospitalier de la Region de Mulhouse et Sud Alsace, Emile Muller Hospital Mulhouse, Alsace, France
  • Hopitaux Universitaires de Strasbourg Strasbourg, Bas-Rhin, France
View all 49 locations
View Trial Details

Related conditions